Overview

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.
Phase:
Phase 3
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma America Inc.